This is a purely administrative filing with no trading implications. Monitor future filings for any material updates on the company's clinical pipeline or capital position.
Price Chart
Executive Summary
Alterity Therapeutics filed a Form 6-K on September 1, 2026, solely to submit an exhibit (Exhibit 99.1) for an application for quotation of securities (ATH). The filing contains no new material financial data, operational updates, or business developments. This is a routine administrative filing related to the listing of securities, with no impact on the company's fundamentals or outlook.
Key Facts
- Filed Form 6-K on September 1, 2026, submitting Exhibit 99.1 for an application for quotation of securities (ATH).
- No new financial results, business updates, or material events disclosed.
- The filing is a routine administrative requirement for a foreign private issuer.
Financial Impact
No financial impact; routine securities quotation application.
Risk Factors
- No new risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-029360 |
| Document: 0001437749-26-029360-index-headers.html | 0001437749-26-029360 |
| Document: 0001437749-26-029360-index.html | 0001437749-26-029360 |
| Document: 0001437749-26-029360.txt | 0001437749-26-029360 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.19 (−4.82%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.19 (+4.82%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.19 (+4.82%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.19 (−8.34%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.19 (−8.34%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.19 (−9.85%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.19 (−29.79%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.19 (−31.97%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.19 (−31.97%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.19 (−40.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers